A Hartford Superior Court jury found Ridgefield, Connecticut-based Boehringer Ingelheim Pharmaceuticals Inc. breached its duty to provide adequate warnings and instructions for the appropriate use of blood thinner Pradaxa, and awarded a New York man $542,465 plus punitive damages.

The six-person jury found in favor of 81-year-old plaintiff Eugene Roberto, whose attorneys said suffered life-threatening bleeding two and a half years after he began taking the drug.